Plans struggle for control of specialty pharma costs.
Carroll
John
J
D001709:Biotechnology / Q000191:economics*; D003363:Cost Control; D016527:Drug Costs / Q000639:trends; D015195:Drug Design; D004345:Drug Industry / Q000191:economics*; D006297:Health Services Accessibility; D006801:Humans; D008329:Managed Care Programs / Q000191:economics*; D012106:Research; D014481:United States